Developmental potential of hematopoietic stem cells determined using retrovirally marked allophenic marrow
- PMID: 1993218
Developmental potential of hematopoietic stem cells determined using retrovirally marked allophenic marrow
Abstract
Genetic markers of two general types have been used to assess the number of simultaneously productive stem cells in vivo, retrovirus markers and enzyme or hemoglobin variants. Use of the two techniques has led to different conclusions regarding stem-cell population organization, kinetics, and usage. To better understand this discrepancy, we have combined the two methods by retrovirally marking and transplanting stem cell populations of allophenic mice in which all tissues, including the hematopoietic system, are chimeric. Hematopoietic and lymphoid tissues of engrafted recipients were analyzed by Southern blotting to determine the number and extent of participation of individually marked stem cells. Genotypic chimerism of the same tissues was determined by quantitating electrophoretic variants of glucose phosphate isomerase. This procedure permitted the genotypic identification of individual stem-cell clones. The results demonstrate the participation of few pluripotent stem cells in the repopulation and maintenance of engrafted hematopoietic and lymphoid tissues. Furthermore, stem cells used during the period of early engraftment tended to be of one genotype (DBA/2), whereas stem cells used for long-term maintenance tended to be of the other, coexistent genotype (C57BL/6). We propose that this genotypic specificity reflects functional differences in stem-cell subpopulations and their relative prevalence in different mouse strains suggests a genetic component in the organization and usage of stem cells.
Similar articles
-
Genotype-restricted growth and aging patterns in hematopoietic stem cell populations of allophenic mice.J Exp Med. 1990 May 1;171(5):1547-65. doi: 10.1084/jem.171.5.1547. J Exp Med. 1990. PMID: 2332731 Free PMC article.
-
Differentiation of chimeric bone marrow in vivo reveals genotype-restricted contributions to hematopoiesis.Exp Hematol. 1991 Oct;19(9):941-9. Exp Hematol. 1991. PMID: 1893972
-
Stem cell quiescence/activation is reversible by serial transplantation and is independent of stromal cell genotype in mouse aggregation chimeras.Exp Hematol. 1992 May;20(4):470-5. Exp Hematol. 1992. PMID: 1568464
-
Stem cell plasticity in muscle and bone marrow.Ann N Y Acad Sci. 2001 Jun;938:208-18; discussion 218-20. doi: 10.1111/j.1749-6632.2001.tb03591.x. Ann N Y Acad Sci. 2001. PMID: 11458510 Review.
-
Bone marrow chimeras-a vital tool in basic and translational research.J Mol Med (Berl). 2019 Jul;97(7):889-896. doi: 10.1007/s00109-019-01783-z. Epub 2019 Apr 26. J Mol Med (Berl). 2019. PMID: 31028417 Review.
Cited by
-
Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level.J Exp Med. 1999 Nov 15;190(10):1493-504. doi: 10.1084/jem.190.10.1493. J Exp Med. 1999. PMID: 10562323 Free PMC article.
-
Senescence of hematopoietic stem cells and bone marrow failure.Int J Hematol. 2005 Oct;82(3):190-5. doi: 10.1532/IJH97.05094. Int J Hematol. 2005. PMID: 16207589 Review.
-
Proliferation of totipotent hematopoietic stem cells in vitro with retention of long-term competitive in vivo reconstituting ability.Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1968-72. doi: 10.1073/pnas.89.5.1968. Proc Natl Acad Sci U S A. 1992. PMID: 1311857 Free PMC article.
-
Genetic control of murine hematopoietic stem cell pool sizes and cycling kinetics.Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11607-11. doi: 10.1073/pnas.89.23.11607. Proc Natl Acad Sci U S A. 1992. PMID: 1280831 Free PMC article.
-
Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures.J Clin Invest. 1992 Jun;89(6):1817-24. doi: 10.1172/JCI115786. J Clin Invest. 1992. PMID: 1601991 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical